Literature DB >> 16624362

Repression of HPV16 early region transcription by the E2 protein.

Emiko Soeda1, Maureen C Ferran, Carl C Baker, Alison A McBride.   

Abstract

HPV16 DNA is often integrated in cancers, disrupting the E1 or E2 genes. E2 can repress the E6/E7 promoter, but other models have been proposed to explain why integration promotes malignant progression. E1 and E2 are required for viral replication, and so genetic analysis of their role in transcriptional regulation is complex. Therefore, we developed an extrachromosomal vector containing HPV16 to undertake a genetic analysis of the E1 and E2 genes. We demonstrate that the E2 protein is primarily a transcriptional repressor when expressed from the virus. Furthermore, repression requires both the transactivation function of E2 and specific binding of E2 to the LCR. We find no evidence that the E1 protein directly modulates HPV16 gene expression. However, certain E1 mutations modulated transcription indirectly by altering splicing of E2 mRNA species. These data provide important insight into which E1 and E2 functions are optimal targets for anti-viral therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624362     DOI: 10.1016/j.virol.2006.03.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression.

Authors:  Jasmin Fertey; Ingo Ammermann; Michael Winkler; Reinhard Stöger; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

2.  Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses.

Authors:  M G McPhillips; J G Oliveira; J E Spindler; R Mitra; A A McBride
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 3.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

4.  Design and characterization of an enhanced repressor of human papillomavirus E2 protein.

Authors:  Kakoli Bose; Gretchen Meinke; Andrew Bohm; James D Baleja
Journal:  FASEB J       Date:  2011-04-11       Impact factor: 5.191

5.  The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci.

Authors:  Nozomi Sakakibara; Ruchira Mitra; Alison A McBride
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

6.  Functional implications of mitochondrial reactive oxygen species generated by oncogenic viruses.

Authors:  Young Bong Choi; Edward William Harhaj
Journal:  Front Biol (Beijing)       Date:  2014-12

7.  Human Papillomavirus Replication Regulation by Acetylation of a Conserved Lysine in the E2 Protein.

Authors:  Yanique Thomas; Elliot J Androphy
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

8.  Characterization of the Human Papillomavirus 16 E8 Promoter.

Authors:  Elke Straub; Jasmin Fertey; Marcel Dreer; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

9.  The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.

Authors:  Wei Li; Wei Wang; Mani Si; Linfei Han; Qinglei Gao; Aiyue Luo; Yan Li; Yunping Lu; Shixuan Wang; Ding Ma
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-14       Impact factor: 4.553

10.  Dimerization of the human papillomavirus type 16 E2 N terminus results in DNA looping within the upstream regulatory region.

Authors:  Elena E Hernandez-Ramon; Julie E Burns; Wenke Zhang; Hannah F Walker; Stephanie Allen; Alfred A Antson; Norman J Maitland
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.